Pre-hypertension and the risk of diabetes mellitus incidence using a marginal structural model in an Iranian prospective cohort study
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
OBJECTIVES: The aim of this study was to evaluate the effect of pre-hypertension and its sub-classification on the development of diabetes. METHODS: In this cohort study, 2,941 people 40 to 64 years old without hypertension or diabetes were followed from 2009 through 2014. According to the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC)-7 criteria, we classified participants into normal and pre-hypertension groups. The effect of pre-hypertension on the 5-year incidence rate of diabetes was studied using inverse probability of treatment weighting. We modeled the exposure and censored cases given confounding factors such as age, sex, body mass index, smoking, economic status, and education. RESULTS: The 5-year incidence rate of diabetes among people with pre-hypertension and those with normal blood pressure (BP) was 12.7 and 9.7%, respectively. The risk ratio (RR) for people with pre-hypertension was estimated to be 1.13 (95% confidence interval [CI], 0.90 to 1.41). The RRs among people with normal BP and high-normal BP, according to the JNC-6 criteria, compared to those with optimal BP were 0.96 (95% CI, 0.73 to 1.25) and 1.31 (95% CI, 1.01 to 1.72), respectively. CONCLUSIONS: Our results showed that participants who had higher levels of BP (high-normal compared to optimal BP) had a higher risk of diabetes development. With regard to the quantitative nature of BP, using the specifically distinguishing of stage 1 hypertension or high-normal BP may be a more meaningful categorization for diabetes risk assessment than the JNC-7 classification.
Abstract
OBJECTIVES: The aim of this study was to evaluate the effect of pre-hypertension and its sub-classification on the development of diabetes. METHODS: In this cohort study, 2,941 people 40 to 64 years old without hypertension or diabetes were followed from 2009 through 2014. According to the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC)-7 criteria, we classified participants into normal and pre-hypertension groups. The effect of pre-hypertension on the 5-year incidence rate of diabetes was studied using inverse probability of treatment weighting. We modeled the exposure and censored cases given confounding factors such as age, sex, body mass index, smoking, economic status, and education. RESULTS: The 5-year incidence rate of diabetes among people with pre-hypertension and those with normal blood pressure (BP) was 12.7 and 9.7%, respectively. The risk ratio (RR) for people with pre-hypertension was estimated to be 1.13 (95% confidence interval [CI], 0.90 to 1.41). The RRs among people with normal BP and high-normal BP, according to the JNC-6 criteria, compared to those with optimal BP were 0.96 (95% CI, 0.73 to 1.25) and 1.31 (95% CI, 1.01 to 1.72), respectively. CONCLUSIONS: Our results showed that participants who had higher levels of BP (high-normal compared to optimal BP) had a higher risk of diabetes development. With regard to the quantitative nature of BP, using the specifically distinguishing of stage 1 hypertension or high-normal BP may be a more meaningful categorization for diabetes risk assessment than the JNC-7 classification.
참고문헌 (33)
- Kearney PM, "Worldwide prevalence of hypertension: a systematic review", J Hypertens, 22, pp.11~19 (2004)[DOI]
- Conen D, "Blood pressure and risk of developing type 2 diabetes mellitus: the Women's Health Study", Eur Heart J, 28, pp.2937~2943 (2007)[DOI]
- Kim MJ, "Hypertension is an independent risk factor for type 2 diabetes: the Korean genome and epidemiology study", Hypertens Res, 38, pp.783~789 (2015)[DOI]
- Lawes CM, "Global burden of blood-pressure-related disease, 2001", Lancet, 371, pp.1513~1518 (2008)[DOI]
- Chobanian AV, "Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure", Hypertension, 42, pp.1206~1252 (2003)[DOI]
- Liszka HA, "Prehypertension and cardiovascular morbidity", Ann Fam Med, 3, pp.294~299 (2005)[DOI]
- Qureshi AI, "Is prehypertension a risk factor for cardiovascular diseases?", Stroke, 36, pp.1859~1863 (2005)[DOI]
- Lozano R, "Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010", Lancet, 380, pp.2095~2128 (2012)[DOI]
- Guariguata L, "Global estimates of diabetes prevalence for 2013 and projections for 2035", Diabetes Res Clin Pract, 103, pp.137~149 (2014)[DOI]
- Emerging Risk Factors Collaboration, "Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies", Lancet, 375, pp.2215~2222 (2010)[DOI]
- "Global health risks: mortality and burden of disease attributable to selected major risks"[URL]
- Haslam DW, "Obesity", Lancet, 366, pp.1197~1209 (2005)[DOI]
- Khosravi A, "The prevalence of pre-hypertension and hypertension in an Iranian urban population", High Blood Press Cardiovasc Prev, 21, pp.127~135 (2014)[DOI]
- Chamarthi B, "Inflammation and hypertension: the interplay of interleukin-6, dietary sodium, and the renin-angiotensin system in humans", Am J Hypertens, 24, pp.1143~1148 (2011)[DOI]
- Taddei S, "Antihypertensive drugs and reversing of endothelial dysfunction in hypertension", Curr Hypertens Rep, 2, pp.64~70 (2000)[DOI]
- Ebrahimi H, "High incidence of diabetes mellitus among a middle-aged population in Iran: a longitudinal study", Can J Diabetes, 40, pp.570~575 (2016)[DOI]
- Ferguson TS, "Prevalence of prehypertension and its relationship to risk factors for cardiovascular disease in Jamaica: analysis from a cross-sectional survey", BMC Cardiovasc Disord, 8, pp.20~ (2008)[DOI]
- Lee JH, "Comparison of risk factors between prehypertension and hypertension in Korean male industrial workers", Public Health Nurs, 23, pp.314~323 (2006)[DOI]
- Mullican DR, "Is prehypertension a risk factor for the development of type 2 diabetes?", Diabetes Care, 32, pp.1870~1872 (2009)[DOI]
- Kaplan NM, "The 6th joint national committee report (JNC-6): new guidelines for hypertension therapy from the USA", Keio J Med, 47, pp.99~105 (1998)[DOI]
- Whelton PK, "2017 ACC", AHA, ABC, pp.ACPM, AGS[DOI]
- Alberti KG, "Metabolic syndrome--a new world-wide definition. A consensus statement from the International Diabetes Federation", Diabet Med, 23, pp.469~480 (2006)[DOI]
- Emdin CA, "Usual blood pressure and risk of new-onset diabetes: evidence from 4.1 million adults and a meta-analysis of prospective studies", J Am Coll Cardiol, 66, pp.1552~1562 (2015)[DOI]
- Fotouhi A, "Cohort profile: Shahroud eye cohort study", Int J Epidemiol, 42, pp.1300~1308 (2013)[DOI]
- American Diabetes Association, "Diagnosis and classification of diabetes mellitus", Diabetes Care, 37(Suppl 1), pp.S81~S90 (2014)[DOI]
- "Causal inference with observational data: a brief review of quasi-experimental methods"[URL]
- Hernan MA, "Estimating causal effects from epidemiological data", J Epidemiol Community Health, 60, pp.578~586 (2006)[DOI]
- Mansournia MA, "Inverse probability weighting", BMJ, 352, pp.i189~ (2016)
- Rasouli M, "The impact of motivational interviewing on participation in childbirth preparation classes and having a natural delivery: a randomised trial", BJOG, 124, pp.631~639 (2017)[DOI]
- Everett CJ, "Evidence that prehypertension is a risk factor for type 2 diabetes", Expert Rev Cardiovasc Ther, 8, pp.335~337 (2010)[DOI]
- Vasan RS, "Impact of high-normal blood pressure on the risk of cardiovascular disease", N Engl J Med, 345, pp.1291~1297 (2001)[DOI]
- Mohammad K, "Marginal versus conditional causal effects", J Biostat Epidemiol, 1, pp.121~128 (2015)
- Gharibzadeh S, "Standardization as a tool for causal inference in medical research", Arch Iran Med, 19, pp.666~670 (2016)